Department of Physical Therapy, University of British Columbia, Vancouver, Canada.
BMC Med Inform Decis Mak. 2013 Dec 1;13:131. doi: 10.1186/1472-6947-13-131.
BACKGROUND: Decision aids are evidence-based tools designed to inform people of the potential benefit and harm of treatment options, clarify their preferences and provide a shared decision-making structure for discussion at a clinic visit. For patients with rheumatoid arthritis (RA) who are considering methotrexate, we have developed a web-based patient decision aid called the ANSWER (Animated, Self-serve, Web-based Research Tool). This study aimed to: 1) assess the usability of the ANSWER prototype; 2) identify strengths and limitations of the ANSWER from the patient's perspective. METHODS: The ANSWER prototype consisted of: 1) six animated patient stories and narrated information on the evidence of methotrexate for RA; 2) interactive questionnaires to clarify patients' treatment preferences. Eligible participants for the usability test were patients with RA who had been prescribed methotrexate. They were asked to verbalize their thoughts (i.e., think aloud) while using the ANSWER, and to complete the System Usability Scale (SUS) to assess overall usability (range = 0-100; higher = more user friendly). Participants were audiotaped and observed, and field notes were taken. The testing continued until no new modifiable issues were found. We used descriptive statistics to summarize participant characteristics and the SUS scores. Content analysis was used to identified usability issues and navigation problems. RESULTS: 15 patients participated in the usability testing. The majority were aged 50 or over and were university/college graduates (n = 8, 53.4%). On average they took 56 minutes (SD = 34.8) to complete the tool. The mean SUS score was 81.2 (SD = 13.5). Content analysis of audiotapes and field notes revealed four categories of modifiable usability issues: 1) information delivery (i.e., clarity of the information and presentation style); 2) navigation control (i.e., difficulties in recognizing and using the navigation control buttons); 3) layout (i.e., position of the videos, text, diagrams and navigation buttons); 4) aesthetic (i.e., the colour, look and feel of the online tool). CONCLUSIONS: Although the SUS score indicated high usability before and after major modification, findings from the think-aloud sessions illustrated areas that required further refinement. Our results highlight the importance of formative evaluation in usability testing.
背景:决策辅助工具是基于证据的工具,旨在告知人们治疗选择的潜在益处和危害,澄清他们的偏好,并为在诊所就诊时的共同决策提供结构。对于考虑使用甲氨蝶呤的类风湿关节炎(RA)患者,我们开发了一个名为 ANSWER(动画、自助、基于网络的研究工具)的基于网络的患者决策辅助工具。本研究旨在:1)评估 ANSWER 原型的可用性;2)从患者的角度确定 ANSWER 的优势和局限性。
方法:ANSWER 原型包括:1)六个动画患者故事和关于甲氨蝶呤治疗 RA 的证据的叙述信息;2)用于澄清患者治疗偏好的交互式问卷。可用性测试的合格参与者是已开甲氨蝶呤处方的 RA 患者。要求他们在使用 ANSWER 时说出自己的想法(即,大声思考),并完成系统可用性量表(SUS)以评估整体可用性(范围为 0-100;分数越高,用户友好性越高)。参与者被录音和观察,并记录现场笔记。测试一直持续到发现没有新的可修改问题为止。我们使用描述性统计来总结参与者的特征和 SUS 分数。内容分析用于确定可用性问题和导航问题。
结果:15 名患者参加了可用性测试。大多数人年龄在 50 岁或以上,并且是大学/学院毕业生(n=8,53.4%)。他们平均需要 56 分钟(SD=34.8)完成该工具。平均 SUS 得分为 81.2(SD=13.5)。对录音带和现场笔记的内容分析揭示了四类可修改的可用性问题:1)信息传递(即,信息的清晰度和呈现风格);2)导航控制(即,识别和使用导航控制按钮的困难);3)布局(即,视频、文本、图表和导航按钮的位置);4)美观(即,在线工具的颜色、外观和感觉)。
结论:尽管 SUS 得分表明在进行重大修改前后具有较高的可用性,但“大声思考”会议的结果表明了需要进一步改进的地方。我们的结果强调了在可用性测试中进行形成性评估的重要性。
BMC Med Inform Decis Mak. 2013-12-1
JMIR Hum Factors. 2015-5-8
Arthritis Care Res (Hoboken). 2014-10
J Med Internet Res. 2010-7-29
Int J Med Inform. 2017-10
JMIR Form Res. 2022-4-8
Arthritis Care Res (Hoboken). 2018-2-6
JMIR Rehabil Assist Technol. 2023-8-15
Can Pharm J (Ott). 2021-5-28
J Diabetes Sci Technol. 2022-7
Patient Prefer Adherence. 2020-8-25
J Am Med Inform Assoc. 2011-8-9
J Med Internet Res. 2010-7-29
J Diabetes Sci Technol. 2010-5-1
Cochrane Database Syst Rev. 2010-5-12